Cargando…
The effect of anti-cancer therapy on immunological response to COVID-19 vaccination
Autores principales: | Jackson-Spence, F.E., Toms, C., Yang, Y-H., Walshaw, L., Caldwell, L., Riddell, A., Cutino-Moguel, M-T., Szabados, B., Propper, D., Powles, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Association of Urology. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155271/ http://dx.doi.org/10.1016/S0302-2838(22)00474-2 |
Ejemplares similares
-
Evaluation of 2 commercial anti-SARS-CoV-2 antibody assays in an immunocompetent and immunocompromised inpatient population with COVID-19
por: Harrington, David, et al.
Publicado: (2021) -
Immunologic Monitoring of Cellular Immune Responses in Cancer Vaccine Therapy
por: Whiteside, Theresa L., et al.
Publicado: (2011) -
Immunological monitoring for prediction of clinical response to antitumor vaccine therapy
por: Mikhaylova, Irina N., et al.
Publicado: (2018) -
Abstracts from the current global iterature: Discordant virological and immunological response in anti-retroviral therapy
por: Bharti, Ankit H., et al.
Publicado: (2013) -
Long-term immunological consequences of anti-CD20 therapies on humoral responses to COVID-19 vaccines in multiple sclerosis: an observational study
por: Moser, Tobias, et al.
Publicado: (2022)